Latin America Diabetes Care Drugs Market Share

Market Share of Latin America Diabetes Care Drugs Industry

The Latin American diabetes care drugs market includes several established global and local players. In Latin America, only a few players significantly share the need for branded drugs. However, the number of players for generic drugs is high, including several local ones. Novo Nordisk holds the largest share in the Latin American diabetes care drug market. Branded drugs from Eli Lilly and Boehringer Ingelheim Alliance are expected to record a high CAGR of more than 15% in the forecast period.

Latin America Diabetes Care Drugs Market Leaders

1. Novo Nordisk

2. Sanofi

3. Eli Lilly

4. AstraZeneca

5. Boehringer Ingelheim

*Disclaimer: Major Players sorted in no particular order